Acetylated Thioredoxin Reductase 1 Resists Oxidative Inactivation

Area of Science:

• Biochemistry
• Enzymology
• Molecular Biology

Background:

• Thioredoxin Reductase 1 (TrxR1) is crucial for cellular defense against oxidative stress and chemotherapy-induced damage.
• Acetylation of TrxR1 is linked to oxidative stress, but its functional role under oxidizing conditions remains unclear.
• Selenocysteine is vital for TrxR1 enzymatic activity.

Purpose of the Study:

• To investigate the functional consequences of TrxR1 acetylation under oxidative stress.
• To compare the effects of site-specific versus non-specific acetylation on TrxR1 stability and activity.
• To elucidate the regulatory mechanisms of TrxR1 in response to oxidative conditions.

Main Methods:

• Genetic code expansion was employed to create recombinant, site-specifically acetylated TrxR1 variants containing selenocysteine.
• Enzymological assays were performed to assess TrxR1 activity, oxidative inactivation, and multimer formation.
• Non-specific acetylation of TrxR1 was induced using aspirin, followed by mass spectrometry analysis.

Main Results:

• Site-specific acetylation at lysine residues enhances TrxR1 activity by modulating dimer and tetramer formation.
• Acetylated TrxR1 exhibits resistance to oxidative inactivation and peroxide-induced multimerization.
• Non-specifically acetylated TrxR1 demonstrates sustained activity under strongly oxidizing conditions, unlike unmodified TrxR1.

Conclusions:

• Both site-specific and general acetylation serve as regulatory mechanisms for TrxR1.
• Acetylation enhances TrxR1's resilience to oxidative damage, preserving its protective cellular functions.
• These findings offer insights into managing oxidative stress in cellular defense and therapeutic contexts.